Covered recipient · General Payments record
SETH D OESCH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2025
$1,148.40
- Reported across 54 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $290.69 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $72.38 | 4 |
| Lilly USA, LLC | $70.30 | 4 |
| Acerta Pharma LLC | $43.97 | 3 |
| Abbott Laboratories | $24.64 | 1 |
| GlaxoSmithKline, LLC. | $21.48 | 1 |
| Exact Sciences Corporation | $21.03 | 1 |
| PFIZER INC. | $19.78 | 1 |
| Novo Nordisk AS | $17.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.64 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240628604 | CMS |
| Amgen Inc. | $17.16 | 01/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228271413 | CMS |
| Amgen Inc. | $14.60 | 02/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227134031 | CMS |
| Amgen Inc. | $18.32 | 07/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228271409 | CMS |
| Amgen Inc. | $22.30 | 09/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228271411 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.42 | 02/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206916428 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.83 | 04/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206260770 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.72 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206378450 | CMS |
| Exact Sciences Corporation | $21.03 | 08/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235282022 | CMS |
| GlaxoSmithKline, LLC. | $21.48 | 04/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190688007 | CMS |
| Lilly USA, LLC | $13.46 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186914296 | CMS |
| Lilly USA, LLC | $14.81 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186891953 | CMS |
| Lilly USA, LLC | $25.61 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186938567 | CMS |
| Lilly USA, LLC | $16.42 | 10/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186900931 | CMS |
| Novo Nordisk Inc | $17.11 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188481009 | CMS |
| PFIZER INC. | $19.78 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231580696 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.